Related Experiment Video
Updated: Aug 6, 2025
Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
Published on: August 25, 2022
Pathogenesis and Prevention of Intraventricular Hemorrhage in Preterm Infants
1Department of Pediatrics, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Insights
Intraventricular hemorrhage (IVH) in preterm infants is common and leads to brain injury. Prevention strategies targeting cerebral blood flow, vessel fragility, and genetic factors can reduce IVH occurrence.
Area of Science:
- Neonatal neurology
- Pediatric critical care
Background:
- Intraventricular hemorrhage (IVH) is a significant concern in preterm infants, leading to brain injury and poor neurodevelopmental outcomes.
- Despite advances, IVH-related morbidity remains high in this vulnerable population.
Purpose of the Study:
- To investigate the pathophysiology of intraventricular hemorrhage (IVH) in preterm infants.
- To review evidence on interventions for preventing IVH.
Main Methods:
- Literature review focusing on cerebral hemodynamics, cerebral vessel structure vulnerabilities, and genetic predisposing factors.
- Analysis of antenatal, perinatal, and postnatal management strategies.
- Examination of neuroprotective care bundles.
Main Results:
- IVH in preterm infants is linked to cerebral blood flow fluctuations, patent ductus arteriosus, CO2 levels, impaired venous drainage, fragile capillaries, and genetic factors.
- Antenatal (corticosteroids, magnesium sulfate), perinatal (maternal transfer), and postnatal (pharmacological agents, circulatory management) interventions can lower IVH risk.
- Neuroprotective care bundles may also reduce IVH incidence.
Conclusions:
- Individualized management considering risk factors and physiological status is crucial for preterm infants.
- Monitoring cerebrovascular and systemic hemodynamic changes is essential.
- Multifaceted strategies are needed to prevent IVH and improve outcomes in preterm infants.
Abstract:
Intraventricular hemorrhage (IVH) is a serious concern for preterm infants and can predispose such infants to brain injury and poor neurodevelopmental outcomes. IVH is particularly common in preterm infants. Although advances in obstetric management and neonatal care have led to a lower mortality rate for preterm infants with IVH, the IVH-related morbidity rate in this population remains high. Therefore, the present review investigated the pathophysiology of IVH and the evidence related to interventions for prevention. The analysis of the pathophysiology of IVH was conducted with a focus on the factors associated with cerebral hemodynamics, vulnerabilities in the structure of cerebral vessels, and host or genetic predisposing factors. The findings presented in the literature indicate that fluctuations in cerebral blood flow, the presence of hemodynamic significant patent ductus arteriosus, arterial carbon dioxide tension, and impaired cerebral venous drainage; a vulnerable or fragile capillary network; and a genetic variant associated with a mechanism underlying IVH development may lead to preterm infants developing IVH. Therefore, strategies focused on antenatal management, such as routine corticosteroid administration and magnesium sulfate use; perinatal management, such as maternal transfer to a specialized center; and postnatal management, including pharmacological agent administration and circulatory management involving prevention of extreme blood pressure, hemodynamic significant patent ductus arteriosus management, and optimization of cardiac function, can lower the likelihood of IVH development in preterm infants. Incorporating neuroprotective care bundles into routine care for such infants may also reduce the likelihood of IVH development. The findings regarding the pathogenesis of IVH further indicate that cerebrovascular status and systemic hemodynamic changes must be analyzed and monitored in preterm infants and that individualized management strategies must be developed with consideration of the risk factors for and physiological status of each preterm infant.
